Our data did not demonstrate any statistically significant correlation between ERCC2 polymorphisms and the risk factors for ovarian cancer, such as BMI (body mass index), smoking status, alcohol consumption, family history of cancer, pregnancy, ascites, HRT, size of tumour, menarche, and the women with ovarian cancer (“data not shown”). Here, ERCC2 is linked to ovarian carcinoma.